
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **Histone Genes (H3-3A, H2BC12, H2AJ, H3-3B, H1-2, H1-0, H2AC6, H2AW, H1-10, H2AZ1, H2AZ2, MACROH2A1):** These genes are involved in chromatin structure and regulation of gene expression. Histone variants can be indicative of proliferative or undifferentiated states.<br>- **Ribosomal and Translation-related Genes (GARS1, IARS1, LARS1, NARS1, DARS1, SARS1):** These aminoacyl-tRNA synthetases are crucial for protein synthesis, often upregulated in rapidly dividing cells.<br>- **Metabolic and Mitochondrial Genes (MTCO2P12, ALDOA, MTLN, UQCRHL):** These genes are involved in energy production and metabolic processes, which are typically upregulated in cells with high metabolic activity.<br>- **Ubiquitination and Protein Degradation (MARCHF5, MARCHF6, GABARAP):** These genes are involved in protein turnover and autophagy, processes that are often active in cancer cells.<br>- **RNA Processing and Stability (TUG1, ZNRD2, RO60):** These genes are involved in RNA processing and stability, which can be critical in cancer cell survival and proliferation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **NIBAN2 (also known as FAM129A):** Often associated with stress response and has been implicated in cancer cell survival.<br>- **PLAAT3 and PLAAT4:** Involved in lipid metabolism, which can be altered in cancer cells.<br>- **SEPTIN9 and SEPTIN2:** Part of the septin family, involved in cell division and cytoskeletal organization, often upregulated in cancer cells.<br>- **MICOS10 and MICOS13:** Part of the mitochondrial contact site and cristae organizing system, important for mitochondrial function, often altered in cancer cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and recent literature, we can cross-reference these markers:<br>- **Histone and ribosomal genes** are often upregulated in proliferative cells, including cancer cells.<br>- **NIBAN2, SEPTIN9, and SEPTIN2** have been associated with various cancer types, including breast cancer, indicating a possible cancerous or proliferative cell type.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Given the high expression of histone genes, ribosomal proteins, and cancer-associated markers like NIBAN2 and SEPTIN9, the most probable general cell type is a **cancer cell**, specifically a **breast cancer cell**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Breast Cancer Epithelial Cells:** Given the expression of histone variants and ribosomal proteins, these cells are likely to be rapidly dividing epithelial cancer cells.<br>2. **Breast Cancer Stem-like Cells:** The presence of histone variants and metabolic genes could indicate a stem-like, undifferentiated state.<br>3. **Breast Cancer Proliferative Cells:** The expression of SEPTIN9 and other cell division-related genes suggests a highly proliferative cancer cell type.<br><br>The most likely subtype, based on the markers, is **Breast Cancer Epithelial Cells**, as these markers align with a profile of rapidly dividing cancerous epithelial cells.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of breast cancer epithelial cells. The high expression of histone genes, ribosomal proteins, and cancer-associated markers like NIBAN2 and SEPTIN9 supports this annotation. These cells are characterized by high proliferation rates and altered metabolic activity, typical of cancerous epithelial cells in breast tissue.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result aligns well with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:<br><br>1. **Marker Consistency:**<br>   - The markers used in the annotation are present in the provided marker list. Key markers such as histone genes (e.g., H3-3A, H2BC12), ribosomal and translation-related genes (e.g., GARS1, IARS1), and cancer-associated markers (e.g., NIBAN2, SEPTIN9) are all included in the list.<br>   - The identified cell type, "breast cancer epithelial cells," is consistent with the expression of these markers, which are indicative of proliferative and cancerous states.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation considers the possibility of subtypes within the cancer cell population, such as breast cancer stem-like cells and proliferative cells. However, the primary annotation as "breast cancer epithelial cells" is strongly supported by the high-ranking markers.<br>   - There is no strong evidence of distinct, non-cancerous cell types based on the provided markers, so the annotation does not require flagging for mixed cell types.<br><br>Overall, the annotation is well-supported by the marker list and the context of the dataset, leading to a valid conclusion of breast cancer epithelial cells as the primary cell type.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Breast Cancer Cell</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Breast Cancer Epithelial Cells</li><li>Breast Cancer Stem-like Cells</li><li>Breast Cancer Proliferative Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough analysis of the marker list, with a focus on identifying the most probable cell types within a human breast cancer dataset. The strengths of the annotation include:<br><br>1. **Correctness of Annotations**: The final annotation identifies "Breast Cancer Epithelial Cells" as the primary cell type, which is consistent with the expression of histone genes, ribosomal proteins, and cancer-associated markers like NIBAN2 and SEPTIN9. These markers are indeed indicative of proliferative and cancerous states, particularly in breast cancer.<br><br>2. **Balanced Consideration of Multiple Markers**: The analysis effectively considers a wide range of markers, including histone genes, ribosomal proteins, metabolic genes, and cancer-associated markers. This balanced approach ensures that the annotation is not overly reliant on a single marker type, which enhances the robustness of the conclusions.<br><br>3. **Comprehensive View of Cell Populations**: The annotation provides a comprehensive view by considering potential subtypes within the cancer cell population, such as "Breast Cancer Stem-like Cells" and "Breast Cancer Proliferative Cells." This consideration of subtypes reflects an understanding of the heterogeneity within cancer cell populations.<br><br>However, there are some areas for improvement:<br><br>1. **Marker Rank Consideration**: While the analysis is thorough, it does not explicitly address the rank or order of the markers in the list. In single-cell annotation, the rank of markers can be crucial, as higher-ranked markers may have more significance in defining the cell type.<br><br>2. **Potential Oversights**: The annotation does not explore the possibility of non-cancerous cell types, which could be present in the dataset. Although the markers strongly suggest a cancerous origin, a brief consideration of other potential cell types could provide a more rounded analysis.<br><br>Overall, the annotation is scientifically accurate and provides a well-rounded view of the cell types present in the dataset. The analysis is well-supported by the marker list and aligns with the context of breast cancer tissue.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    